Login Get Started
Browse
Shares
Healthcare
Pharmaceuticals
BioDelivery Sciences International Inc
BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc Share News

$5.56 0.3  5.3%

Last Trade - 21/02/20

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Momentum Trap
Market Cap £384.9m
Enterprise Value £387.0m
Revenue £75.4m
Position in Universe 2999th / 6408
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions BDSI Dividends
All News
All News Reuters News Company Announcements
BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Thu 1:00pm News
BRIEF-BDSI Sees FY 2020 Sales $150 Million To $160 Million
13th Jan News
BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Access for Symproic
13th Jan News
BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development
6th Jan News
BRIEF-Broadfin Capital Reports A 6.8% Stake In Biodelivery Sciences As Of Dec. 18, 2019 - SEC Filing
24th Dec '19 News
BioDelivery Sciences Added to NASDAQ Biotechnology Index
19th Dec '19 News
BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference
27th Nov '19 News
BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors
25th Nov '19 News
BRIEF-Biodelivery Sciences International Expects Full Year 2020 Total Company Net Sales Of $165 Million - $175 Million
12th Nov '19 News
BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations
12th Nov '19 News
BioDelivery Sciences to Present at the 10th Annual Jefferies Global Healthcare Conference in London
7th Nov '19 News
BioDelivery Sciences to Report Third Quarter 2019 Financial Results and Host Conference Call on November 12, 2019
30th Oct '19 News
BRIEF-Biodelivery Sciences Announces Additional Insurance Coverage For Belbuca And Symproic
1st Oct '19 News
BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic®
1st Oct '19 News
BioDelivery Sciences Announces Participation in Upcoming Investor Conferences
17th Sep '19 News
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
29th Aug '19 News
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28th Aug '19 News
BRIEF-Biodelivery Sciences International Q2 GAAP Loss Per Share $0.13
8th Aug '19 News
BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations
8th Aug '19 News
BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
30th Jul '19 News
© Stockopedia 2020, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.